These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 11739462

  • 1. E2 supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion.
    Anderson SM, Wideman L, Patrie JT, Weltman A, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5904-11. PubMed ID: 11739462
    [Abstract] [Full Text] [Related]

  • 2. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD, Evans WS, Bowers CY.
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [Abstract] [Full Text] [Related]

  • 3. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.
    Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):551-60. PubMed ID: 11158008
    [Abstract] [Full Text] [Related]

  • 4. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N, Evans WS, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [Abstract] [Full Text] [Related]

  • 5. Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
    Richmond E, Rogol AD, Basdemir D, Veldhuis OL, Clarke W, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3837-44. PubMed ID: 12161519
    [Abstract] [Full Text] [Related]

  • 6. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS, Anderson SM, Hull LT, Azimi PP, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [Abstract] [Full Text] [Related]

  • 7. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N, Evans WS, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
    [Abstract] [Full Text] [Related]

  • 8. Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu.
    Veldhuis JD, Evans WS, Bowers CY.
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5484-9. PubMed ID: 14602794
    [Abstract] [Full Text] [Related]

  • 9. Contrasting negative-feedback control of endogenously driven and exercise-stimulated pulsatile growth hormone secretion in women and men.
    Veldhuis JD, Patrie J, Wideman L, Patterson M, Weltman JY, Weltman A.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):840-6. PubMed ID: 14764803
    [Abstract] [Full Text] [Related]

  • 10. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
    [Abstract] [Full Text] [Related]

  • 11. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
    Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD.
    J Clin Endocrinol Metab; 2004 May; 89(5):2290-300. PubMed ID: 15126555
    [Abstract] [Full Text] [Related]

  • 12. Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women.
    Veldhuis JD, Anderson SM, Kok P, Iranmanesh A, Frystyk J, Ørskov H, Keenan DM.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1312-8. PubMed ID: 15001627
    [Abstract] [Full Text] [Related]

  • 13. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
    Huhn WC, Hartman ML, Pezzoli SS, Thorner MO.
    J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
    [Abstract] [Full Text] [Related]

  • 14. Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive.
    Veldhuis JD, Anderson SM, Patrie JT, Bowers CY.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):121-7. PubMed ID: 14715838
    [Abstract] [Full Text] [Related]

  • 15. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.
    Bray MJ, Vick TM, Shah N, Anderson SM, Rice LW, Iranmanesh A, Evans WS, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179
    [Abstract] [Full Text] [Related]

  • 16. Age and secretagogue type jointly determine dynamic growth hormone responses to exogenous insulin-like growth factor-negative feedback in healthy men.
    Veldhuis JD, Weltman JY, Weltman AL, Iranmanesh A, Muller EE, Bowers CY.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5542-8. PubMed ID: 15531509
    [Abstract] [Full Text] [Related]

  • 17. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
    Gentili A, Mulligan T, Godschalk M, Clore J, Patrie J, Iranmanesh A, Veldhuis JD.
    J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328
    [Abstract] [Full Text] [Related]

  • 18. Short-term testosterone supplementation relieves growth hormone autonegative feedback in men.
    Veldhuis JD, Evans WS, Iranmanesh A, Weltman AL, Bowers CY.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1285-90. PubMed ID: 15001624
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
    Catalina PF, Mallo F, Andrade MA, García-Mayor RV, Diéguez C.
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3663-7. PubMed ID: 9768681
    [Abstract] [Full Text] [Related]

  • 20. Activation of somatostatin-receptor subtype-2/-5 suppresses the mass, frequency, and irregularity of growth hormone (GH)-releasing peptide-2-stimulated GH secretion in men.
    Iranmanesh A, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4581-7. PubMed ID: 15356066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.